Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Meza

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Biochemical and Biophysical Research Communications|September 22, 2014
CD4 aptamer-RORγt shRNA chimera inhibits IL-17 synthesis by human CD4(+) T cellsPingfang Song, Yuan K Chou, Xiaowei Zhang, et al.
The Journal of Biological Chemistry|May 30, 2003
Production, characterization, and immunogenicity of a soluble rat single chain T cell receptor specific for an encephalitogenic peptideRachel H McMahan, Lisa Watson, Roberto Meza-Romero, et al.
Eneuro|May 3, 2019
Resetting the Respiratory Rhythm with a Spinal Central Pattern GeneratorRoberto Meza, Nayeli Huidobro, Mayra Moreno-Castillo, et al.
Cytokine|August 31, 2016
Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74Roberto Meza-Romero, Gil Benedek, Kelley Jordan, et al.
CNS Neuroscience & Therapeutics|April 3, 2020
Spleen participation in partial MHC class II construct neuroprotection in strokeJohn Brown, Chase Kingsbury, Jea-Young Lee, et al.
Metabolic Brain Disease|March 7, 2012
Gilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitisGregory G Burrows, Roberto Meza-Romero, Jianya Huan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activationChunhe Wang, Jeffery L Mooney, Roberto Meza-Romero, et al.
Metabolic Brain Disease|October 15, 2013
A novel HLA-DRα1-MOG-35-55 construct treats experimental strokeGil Benedek, Wenbin Zhu, Nicole Libal, et al.
European Journal of Immunology|April 12, 2013
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effectsGil Benedek, Roberto Meza-Romero, Shayne Andrew, et al.
Cellular Immunology|October 5, 2021
Brief report: Enhanced DRα1-mMOG-35-55 treatment of severe EAE in MIF-1-deficient male miceArthur A Vandenbark, Roberto Meza-Romero, Jack Wiedrick, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|September 22, 2014
CD4 aptamer-RORγt shRNA chimera inhibits IL-17 synthesis by human CD4(+) T cellsPingfang Song, Yuan K Chou, Xiaowei Zhang, et al.
The Journal of Biological Chemistry|May 30, 2003
Production, characterization, and immunogenicity of a soluble rat single chain T cell receptor specific for an encephalitogenic peptideRachel H McMahan, Lisa Watson, Roberto Meza-Romero, et al.
Eneuro|May 3, 2019
Resetting the Respiratory Rhythm with a Spinal Central Pattern GeneratorRoberto Meza, Nayeli Huidobro, Mayra Moreno-Castillo, et al.
Cytokine|August 31, 2016
Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74Roberto Meza-Romero, Gil Benedek, Kelley Jordan, et al.
CNS Neuroscience & Therapeutics|April 3, 2020
Spleen participation in partial MHC class II construct neuroprotection in strokeJohn Brown, Chase Kingsbury, Jea-Young Lee, et al.
Metabolic Brain Disease|March 7, 2012
Gilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitisGregory G Burrows, Roberto Meza-Romero, Jianya Huan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activationChunhe Wang, Jeffery L Mooney, Roberto Meza-Romero, et al.
Metabolic Brain Disease|October 15, 2013
A novel HLA-DRα1-MOG-35-55 construct treats experimental strokeGil Benedek, Wenbin Zhu, Nicole Libal, et al.
European Journal of Immunology|April 12, 2013
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effectsGil Benedek, Roberto Meza-Romero, Shayne Andrew, et al.
Cellular Immunology|October 5, 2021
Brief report: Enhanced DRα1-mMOG-35-55 treatment of severe EAE in MIF-1-deficient male miceArthur A Vandenbark, Roberto Meza-Romero, Jack Wiedrick, et al.
Pageof 4